Searching retatrutide dosing usually returns one of two things: trial protocols measured in weekly milligrams, or forum posts describing syringe units after reconstitution. Those are different numbers describing different things, and mixing them up is the most common source of error in this compound. This page separates the trial dose from the concentration you create when you reconstitute a vial — and shows the arithmetic that connects them.
Quick Breakdown: Retatrutide Dosing at a Glance
Quick Answer: In the published trial programme, retatrutide has been given as a once-weekly subcutaneous dose that is escalated in fixed steps over several months, starting low and titrating upward. In laboratory work, the equivalent arithmetic is a reconstitution concentration — milligrams of peptide per millilitre of diluent — which you then convert into syringe units. Trials quote milligrams. A reconstituted vial gives you mg/mL.| Term | What It Means | Where You See It |
|---|---|---|
| Dose (mg) | The mass of peptide delivered in one administration. | Trial protocols, published papers, clinical summaries. |
| Concentration (mg/mL) | How much peptide is dissolved per millilitre of diluent. Set entirely by how much water you add. | Reconstitution labels, calculator outputs. |
| Syringe units | The tick marks on a U-100 insulin syringe, where 100 units = 1 mL. | Bench work, protocol logs, unit conversions. |
| Titration | Escalating the dose in steps rather than starting at the target. | Trial design, and the reason GI effects cluster around dose increases. |
What Retatrutide Is, In One Paragraph
Retatrutide (LY3437943) is an investigational triple agonist acting on GIP, GLP-1 and glucagon receptors. The addition of glucagon receptor activity is what distinguishes it from dual agonists like tirzepatide, and it is the reason the compound is discussed as a separate generation rather than a variant. For the receptor pharmacology and trial evidence in detail, read the retatrutide guide.
The trial figures describe what those protocols delivered. They are not a description of what a vial contains, and the conversion between the two is the whole subject of this page.
How Trial Dosing Is Structured
Across the retatrutide trial programme, the pattern is consistent with the wider incretin class:
- Weekly administration. The dosing interval studied is once per week, not daily.
- Stepwise escalation. Participants start at a low dose and increase at fixed intervals — typically every four weeks — until they reach the assigned maintenance dose or the maximum tolerated step.
- Fixed maintenance. Once at target, the dose stays constant for the remainder of the treatment period.
- Discontinuation for intolerance. Escalation exists because gastrointestinal effects are dose-dependent; the step size and the interval between steps are the two variables that most affect tolerability.
Escalation is not a formality. It is the mechanism by which a compound that produces marked GI effects at full dose becomes tolerable — which is why any discussion of dosing that skips titration is describing something the trials did not do.
From Vial to Syringe: The Reconstitution Arithmetic
The vial does not contain a dose. It contains mass. What you do with the diluent determines the concentration, and the concentration determines what a tick mark means. Three numbers govern everything:
- Peptide mass in the vial — printed on the label, in milligrams.
- Volume of diluent added — your choice, recorded in millilitres.
- Syringe calibration — on a U-100 syringe, 1 mL = 100 units, so 1 unit = 0.01 mL.
| Vial Strength | Diluent Added | Resulting Concentration | Per Syringe Unit (U-100) |
|---|---|---|---|
| 10 mg | 2.0 mL | 5.0 mg/mL (5,000 mcg/mL) | 50 mcg per unit |
| 20 mg | 2.0 mL | 10.0 mg/mL (10,000 mcg/mL) | 100 mcg per unit |
| 30 mg | 3.0 mL | 10.0 mg/mL (10,000 mcg/mL) | 100 mcg per unit |
| 30 mg | 2.0 mL | 15.0 mg/mL (15,000 mcg/mL) | 150 mcg per unit |
The pattern is worth internalising: doubling the diluent halves the concentration and doubles the volume needed for the same mass. Adding more water does not change how much peptide is in the vial — it changes how finely you can measure it. If a target draw lands on two or three units, the concentration is too high for accurate measurement, and more diluent is the fix. Our guide to how much bacteriostatic water to add covers that trade-off in detail, and the Peptide Calculator does the conversion for any vial and volume.
Reconstitution Practice That Affects the Numbers
- Use the diluent the compound needs. Standard practice is preserved bacteriostatic water; a few hydrophobic compounds need an acidic primer first, which is covered in which compounds cannot use regular BAC water alone.
- Add the diluent down the glass wall. Spraying directly onto the cake under vacuum creates foam and incomplete dissolution, which makes your concentration wrong before you have drawn anything.
- Record the volume you actually added. Every downstream calculation depends on it. A protocol log with vial mass, diluent volume and puncture date is the difference between a reproducible series and a guess.
- Do not adjust concentration to fix a measurement error. If a draw looks wrong, re-check the arithmetic rather than adding water to compensate.
Frequently Asked Questions
What is the difference between "retatrutide dosing" and "retatrutide dosage"?
Nothing. Both refer to the amount administered, and the terms are used interchangeably in the literature and in search. We treat them as one query rather than splitting the topic across two pages.
What dose does the research use?
Trial protocols used weekly subcutaneous dosing escalated in fixed steps over months, with the maintenance dose varying by trial arm. Those figures belong to the trial protocols and the papers behind them — not to a research vial, and not to a self-directed protocol. The guide summarises the published schedule.
How do I convert milligrams to syringe units?
Divide the peptide mass by the diluent volume to get mg/mL, multiply by 1,000 for mcg/mL, then divide by 100 to get mcg per unit on a U-100 syringe. The table above does it for common vial sizes; the calculator does it for any combination.
Does more diluent mean a stronger solution?
The opposite. Mass stays fixed; adding diluent lowers the concentration and raises the volume required for the same mass.
What Retatrutide Costs — and Why There Is No Pharmacy Version
Unlike the older incretins, retatrutide has no brand name, no prescription pathway and no insurance code. It is still in trials, which means there is no pharmacy shelf to compare against and no "official version" to be measured against. The usual question — brand versus alternative — does not apply here at all.
What remains is the vial: the strength, the price per milligram, and whether the batch you receive matches a published certificate. That is the entire decision.
| Vial Strength | Price | Cost Per Milligram | Per Unit (U-100, 2 mL) |
|---|---|---|---|
| 5 mg | $50 | $10.00 / mg | 50 mcg per unit |
| 10 mg | $70 | $7.00 / mg | 50 mcg per unit |
| 20 mg | $110 | $5.50 / mg | 100 mcg per unit |
| 30 mg | $130 | $4.33 / mg | 150 mcg per unit |
Cost per milligram falls as the vial gets larger — $10.00 at 5 mg down to $4.33 at 30 mg. See the retatrutide product page for current stock.
Related: for the adverse-event profile reported in trials, see retatrutide side effects; to compare vial strengths and order, see where to buy retatrutide in Canada; for the approval status and whether it can be obtained in Canada, see is retatrutide available in Canada.
Retatrutide Priced Per Milligram
Vials at $50 for 5 mg, $70 for 10 mg, $110 for 20 mg and $130 for 30 mg — $10.00 down to $4.33 per milligram. Dispatched from British Columbia in 24–48 hours. View Retatrutide Vials →→ Read the Full Retatrutide Guide: Mechanisms and Trial Evidence
Premium Collection
Explore selected research products.
✓ COA
✓ COA
Somatropin Human Growth Hormone (HGH) 10-Vial Kit
✓ COA
Free resource
New to peptide research?
The free 51-page guide covers 12 compound profiles, reconstitution math, COA reading and storage — without the hype.
Get the free guide →Or start with the 2-page checklist
2 comments